Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models.

Panda SK, Facchinetti V, Voynova E, Hanabuchi S, Karnell JL, Hanna RN, Kolbeck R, Sanjuan MA, Ettinger R, Liu YJ.

J Clin Invest. 2018 May 1;128(5):1873-1887. doi: 10.1172/JCI97333. Epub 2018 Apr 3.

2.

Potent Immune Modulation by MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion Protein.

Oberst MD, Augé C, Morris C, Kentner S, Mulgrew K, McGlinchey K, Hair J, Hanabuchi S, Du Q, Damschroder M, Feng H, Eck S, Buss N, de Haan L, Pierce AJ, Park H, Sylwester A, Axthelm MK, Picker L, Morris NP, Weinberg A, Hammond SA.

Mol Cancer Ther. 2018 May;17(5):1024-1038. doi: 10.1158/1535-7163.MCT-17-0200. Epub 2018 Mar 15.

PMID:
29545330
3.

NFATC3 promotes IRF7 transcriptional activity in plasmacy--toid dendritic cells.

Bao M, Wang Y, Liu Y, Shi P, Lu H, Sha W, Weng L, Hanabuchi S, Qin J, Plumas J, Chaperot L, Zhang Z, Liu YJ.

J Exp Med. 2016 Oct 17;213(11):2383-2398. Epub 2016 Oct 3.

4.

Human NLRP3 inflammasome senses multiple types of bacterial RNAs.

Sha W, Mitoma H, Hanabuchi S, Bao M, Weng L, Sugimoto N, Liu Y, Zhang Z, Zhong J, Sun B, Liu YJ.

Proc Natl Acad Sci U S A. 2014 Nov 11;111(45):16059-64. doi: 10.1073/pnas.1412487111. Epub 2014 Oct 29.

5.

Helicase proteins DHX29 and RIG-I cosense cytosolic nucleic acids in the human airway system.

Sugimoto N, Mitoma H, Kim T, Hanabuchi S, Liu YJ.

Proc Natl Acad Sci U S A. 2014 May 27;111(21):7747-52. doi: 10.1073/pnas.1400139111. Epub 2014 May 12.

6.

Proatherogenic conditions promote autoimmune T helper 17 cell responses in vivo.

Lim H, Kim YU, Sun H, Lee JH, Reynolds JM, Hanabuchi S, Wu H, Teng BB, Chung Y.

Immunity. 2014 Jan 16;40(1):153-65. doi: 10.1016/j.immuni.2013.11.021. Epub 2014 Jan 9.

7.

The DHX33 RNA helicase senses cytosolic RNA and activates the NLRP3 inflammasome.

Mitoma H, Hanabuchi S, Kim T, Bao M, Zhang Z, Sugimoto N, Liu YJ.

Immunity. 2013 Jul 25;39(1):123-35. doi: 10.1016/j.immuni.2013.07.001. Epub 2013 Jul 18.

8.

PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma.

Zheng Y, Yang J, Qian J, Qiu P, Hanabuchi S, Lu Y, Wang Z, Liu Z, Li H, He J, Lin P, Weber D, Davis RE, Kwak L, Cai Z, Yi Q.

Leukemia. 2013 Mar;27(3):702-10. doi: 10.1038/leu.2012.272. Epub 2012 Sep 21.

9.

Plasmacytoid dendritic cells promote immunosuppression in ovarian cancer via ICOS costimulation of Foxp3(+) T-regulatory cells.

Conrad C, Gregorio J, Wang YH, Ito T, Meller S, Hanabuchi S, Anderson S, Atkinson N, Ramirez PT, Liu YJ, Freedman R, Gilliet M.

Cancer Res. 2012 Oct 15;72(20):5240-9. doi: 10.1158/0008-5472.CAN-12-2271. Epub 2012 Jul 31.

10.

CD2AP/SHIP1 complex positively regulates plasmacytoid dendritic cell receptor signaling by inhibiting the E3 ubiquitin ligase Cbl.

Bao M, Hanabuchi S, Facchinetti V, Du Q, Bover L, Plumas J, Chaperot L, Cao W, Qin J, Sun SC, Liu YJ.

J Immunol. 2012 Jul 15;189(2):786-92. doi: 10.4049/jimmunol.1200887. Epub 2012 Jun 15.

11.

Phospholipid scramblase 1 regulates Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells.

Talukder AH, Bao M, Kim TW, Facchinetti V, Hanabuchi S, Bover L, Zal T, Liu YJ.

Cell Res. 2012 Jul;22(7):1129-39. doi: 10.1038/cr.2012.45. Epub 2012 Mar 27.

12.

TSLP and immune homeostasis.

Hanabuchi S, Watanabe N, Liu YJ.

Allergol Int. 2012 Mar;61(1):19-25. doi: 10.2332/allergolint.11-RAI-0394. Epub 2012 Jan 25. Review.

13.

In vivo role of pDCs in regulating adaptive immunity.

Hanabuchi S, Liu YJ.

Immunity. 2011 Dec 23;35(6):851-3. doi: 10.1016/j.immuni.2011.12.005.

14.

Aspartate-glutamate-alanine-histidine box motif (DEAH)/RNA helicase A helicases sense microbial DNA in human plasmacytoid dendritic cells.

Kim T, Pazhoor S, Bao M, Zhang Z, Hanabuchi S, Facchinetti V, Bover L, Plumas J, Chaperot L, Qin J, Liu YJ.

Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15181-6. doi: 10.1073/pnas.1006539107. Epub 2010 Aug 9.

15.

Thymic stromal lymphopoietin-activated plasmacytoid dendritic cells induce the generation of FOXP3+ regulatory T cells in human thymus.

Hanabuchi S, Ito T, Park WR, Watanabe N, Shaw JL, Roman E, Arima K, Wang YH, Voo KS, Cao W, Liu YJ.

J Immunol. 2010 Mar 15;184(6):2999-3007. doi: 10.4049/jimmunol.0804106. Epub 2010 Feb 19.

16.

Distinct signal codes generate dendritic cell functional plasticity.

Arima K, Watanabe N, Hanabuchi S, Chang M, Sun SC, Liu YJ.

Sci Signal. 2010 Jan 19;3(105):ra4. doi: 10.1126/scisignal.2000567.

17.

TSLP production by epithelial cells exposed to immunodeficiency virus triggers DC-mediated mucosal infection of CD4+ T cells.

Fontenot D, He H, Hanabuchi S, Nehete PN, Zhang M, Chang M, Nehete B, Wang YH, Wang YH, Ma ZM, Lee HC, Ziegler SF, Courtney AN, Miller CJ, Sun SC, Liu YJ, Sastry KJ.

Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16776-81. doi: 10.1073/pnas.0907347106. Epub 2009 Sep 21.

18.

TSLP and IL-7 use two different mechanisms to regulate human CD4+ T cell homeostasis.

Lu N, Wang YH, Wang YH, Arima K, Hanabuchi S, Liu YJ.

J Exp Med. 2009 Sep 28;206(10):2111-9. doi: 10.1084/jem.20090153. Epub 2009 Sep 21.

19.

Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction.

Cao W, Bover L, Cho M, Wen X, Hanabuchi S, Bao M, Rosen DB, Wang YH, Shaw JL, Du Q, Li C, Arai N, Yao Z, Lanier LL, Liu YJ.

J Exp Med. 2009 Jul 6;206(7):1603-14. doi: 10.1084/jem.20090547. Epub 2009 Jun 29.

20.

Identification of IL-17-producing FOXP3+ regulatory T cells in humans.

Voo KS, Wang YH, Santori FR, Boggiano C, Wang YH, Arima K, Bover L, Hanabuchi S, Khalili J, Marinova E, Zheng B, Littman DR, Liu YJ.

Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4793-8. doi: 10.1073/pnas.0900408106. Epub 2009 Mar 9.

21.

Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines.

Buglio D, Georgakis GV, Hanabuchi S, Arima K, Khaskhely NM, Liu YJ, Younes A.

Blood. 2008 Aug 15;112(4):1424-33. doi: 10.1182/blood-2008-01-133769. Epub 2008 Jun 9.

22.

Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery.

Ito T, Hanabuchi S, Wang YH, Park WR, Arima K, Bover L, Qin FX, Gilliet M, Liu YJ.

Immunity. 2008 Jun;28(6):870-80. doi: 10.1016/j.immuni.2008.03.018. Epub 2008 May 29.

23.

IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells.

Wang YH, Angkasekwinai P, Lu N, Voo KS, Arima K, Hanabuchi S, Hippe A, Corrigan CJ, Dong C, Homey B, Yao Z, Ying S, Huston DP, Liu YJ.

J Exp Med. 2007 Aug 6;204(8):1837-47. Epub 2007 Jul 16.

24.

OX40 ligand shuts down IL-10-producing regulatory T cells.

Ito T, Wang YH, Duramad O, Hanabuchi S, Perng OA, Gilliet M, Qin FX, Liu YJ.

Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13138-43. Epub 2006 Aug 21.

25.

Human plasmacytoid predendritic cells activate NK cells through glucocorticoid-induced tumor necrosis factor receptor-ligand (GITRL).

Hanabuchi S, Watanabe N, Wang YH, Wang YH, Ito T, Shaw J, Cao W, Qin FX, Liu YJ.

Blood. 2006 May 1;107(9):3617-23. Epub 2006 Jan 5.

26.

Human TSLP promotes CD40 ligand-induced IL-12 production by myeloid dendritic cells but maintains their Th2 priming potential.

Watanabe N, Hanabuchi S, Marloie-Provost MA, Antonenko S, Liu YJ, Soumelis V.

Blood. 2005 Jun 15;105(12):4749-51. Epub 2005 Mar 1.

27.

Potential immunogenicity of adult T cell leukemia cells in vivo.

Kurihara K, Harashima N, Hanabuchi S, Masuda M, Utsunomiya A, Tanosaki R, Tomonaga M, Ohashi T, Hasegawa A, Masuda T, Okamura J, Tanaka Y, Kannagi M.

Int J Cancer. 2005 Mar 20;114(2):257-67.

28.

Immunological risks of adult T-cell leukemia at primary HTLV-I infection.

Kannagi M, Ohashi T, Harashima N, Hanabuchi S, Hasegawa A.

Trends Microbiol. 2004 Jul;12(7):346-52. Review.

PMID:
15223062
29.

Repression of tax expression is associated both with resistance of human T-cell leukemia virus type 1-infected T cells to killing by tax-specific cytotoxic T lymphocytes and with impaired tumorigenicity in a rat model.

Nomura M, Ohashi T, Nishikawa K, Nishitsuji H, Kurihara K, Hasegawa A, Furuta RA, Fujisawa J, Tanaka Y, Hanabuchi S, Harashima N, Masuda T, Kannagi M.

J Virol. 2004 Apr;78(8):3827-36.

30.

Human thymic stromal lymphopoietin promotes dendritic cell-mediated CD4+ T cell homeostatic expansion.

Watanabe N, Hanabuchi S, Soumelis V, Yuan W, Ho S, de Waal Malefyt R, Liu YJ.

Nat Immunol. 2004 Apr;5(4):426-34. Epub 2004 Feb 29.

PMID:
14991051
31.

Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation.

Harashima N, Kurihara K, Utsunomiya A, Tanosaki R, Hanabuchi S, Masuda M, Ohashi T, Fukui F, Hasegawa A, Masuda T, Takaue Y, Okamura J, Kannagi M.

Cancer Res. 2004 Jan 1;64(1):391-9.

32.

Human dendritic cells activated by TSLP and CD40L induce proallergic cytotoxic T cells.

Gilliet M, Soumelis V, Watanabe N, Hanabuchi S, Antonenko S, de Waal-Malefyt R, Liu YJ.

J Exp Med. 2003 Apr 21;197(8):1059-63.

33.
35.

[Immunological analysis and experimental immunotherapy for HTLV-I-infected T lymphoproliferative disease in a rat model].

Ohashi T, Hanabuchi S, Kannagi M.

Nihon Rinsho Meneki Gakkai Kaishi. 2002 Feb;25(1):65-9. Review. Japanese. No abstract available.

PMID:
11963182
36.

Regression of human T-cell leukemia virus type I (HTLV-I)-associated lymphomas in a rat model: peptide-induced T-cell immunity.

Hanabuchi S, Ohashi T, Koya Y, Kato H, Hasegawa A, Takemura F, Masuda T, Kannagi M.

J Natl Cancer Inst. 2001 Dec 5;93(23):1775-83.

PMID:
11734593
37.

Immunological aspects of rat models of HTLV type 1-infected T lymphoproliferative disease.

Kannagi M, Ohashi T, Hanabuchi S, Kato H, Koya Y, Hasegawa A, Masuda T, Yoshiki T.

AIDS Res Hum Retroviruses. 2000 Nov 1;16(16):1737-40.

PMID:
11080819
38.

Prevention of adult T-cell leukemia-like lymphoproliferative disease in rats by adoptively transferred T cells from a donor immunized with human T-cell leukemia virus type 1 Tax-coding DNA vaccine.

Ohashi T, Hanabuchi S, Kato H, Tateno H, Takemura F, Tsukahara T, Koya Y, Hasegawa A, Masuda T, Kannagi M.

J Virol. 2000 Oct;74(20):9610-6.

39.

Development of human T-cell leukemia virus type 1-transformed tumors in rats following suppression of T-cell immunity by CD80 and CD86 blockade.

Hanabuchi S, Ohashi T, Koya Y, Kato H, Takemura F, Hirokawa K, Yoshiki T, Yagita H, Okumura K, Kannagi M.

J Virol. 2000 Jan;74(1):428-35.

40.

Establishment of a seronegative human T-cell leukemia virus type 1 (HTLV-1) carrier state in rats inoculated with a syngeneic HTLV-1-immortalized T-cell line preferentially expressing Tax.

Koya Y, Ohashi T, Kato H, Hanabuchi S, Tsukahara T, Takemura F, Etoh K, Matsuoka M, Fujii M, Kannagi M.

J Virol. 1999 Aug;73(8):6436-43.

41.
42.

Oral administration of human T-cell leukemia virus type 1 induces immune unresponsiveness with persistent infection in adult rats.

Kato H, Koya Y, Ohashi T, Hanabuchi S, Takemura F, Fujii M, Tsujimoto H, Hasegawa A, Kannagi M.

J Virol. 1998 Sep;72(9):7289-93.

43.

Fas-mediated cytotoxicity--a new immunoregulatory and pathogenic function of Th1 CD4+ T cells.

Yagita H, Hanabuchi S, Asano Y, Tamura T, Nariuchi H, Okumura K.

Immunol Rev. 1995 Aug;146:223-39. Review. No abstract available.

PMID:
7493756
44.

Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity.

Hanabuchi S, Koyanagi M, Kawasaki A, Shinohara N, Matsuzawa A, Nishimura Y, Kobayashi Y, Yonehara S, Yagita H, Okumura K.

Proc Natl Acad Sci U S A. 1994 May 24;91(11):4930-4.

45.

[Cytotoxicity and apoptosis].

Okumura K, Hanabuchi S, Yagita H.

Ryumachi. 1994 Apr;34(2):187-8. Japanese. No abstract available.

PMID:
8202840

Supplemental Content

Loading ...
Support Center